门诊环境下胫动脉腔内介入治疗与医院环境同样安全有效
该回顾性研究比较了2011年4月至2013年9月间在门诊腔内中心(n=100)与医院血管造影室(n=104)进行的204例外周胫动脉介入治疗,发现两组30天局部并发症、全身并发症及死亡率无统计学差异,门诊组非计划入院率更低(2% vs 11%,p=0.01),1年通畅率数值上更优但未达统计学显著。
要点
- 门诊与医院两组30天局部并发症(7% vs 11%,p=0.368)、全身并发症(4% vs 8%,p=0.263)及死亡率(1% vs 2%,p=0.596)无统计学差异。
- 门诊组非计划入院率低于医院组(2% vs 11%,p=0.01)。
- 1年一期通畅率门诊组69% vs 医院组53%(p=0.050),差异未达统计学显著。
核心结论
- 门诊与医院环境下胫动脉腔内介入治疗的有效性和安全性相似,门诊组非计划入院率更低且通畅率数值更优。
- 作者认为,在适当选择患者的前提下,门诊腔内中心可作为医院血管造影室的安全替代方案。
研究设计与样本
- 回顾性研究,纳入2011年4月至2013年9月间161例患者(平均年龄72±11.5岁,男性81例)的204例门诊胫动脉介入治疗,门诊组n=100,医院组n=104。
- 纳入标准为存在完全位于胫动脉三分叉近端的同侧旁路或既往接受过近端腔内介入治疗;排除标准包括既往同侧旁路累及膝下血管、术中为住院状态、计划术后入院及膝下支架植入。
- 治疗方式为经皮腔内血管成形术(PTA)或PTA联合斑块旋切术。
主要发现
- 医院组慢性阻塞性肺疾病(16% vs 8%,p=0.045)、肾功能不全(37% vs 25%,p=0.017)及既往近端旁路(12% vs 4%,p=0.045)比例高于门诊组。
- 门诊组100例中25例接受PTA、75例接受PTA联合斑块旋切术;医院组104例中68例接受PTA、36例接受PTA联合斑块旋切术。
- 门诊组与医院组30天局部并发症率(7% vs 11%,p=0.368)、全身并发症率(4% vs 8%,p=0.263)及死亡率(1% vs 2%,p=0.596)无统计学差异。
- 门诊组因内科原因非计划入院率低于医院组(2% vs 11%,p=0.01)。
- 1年随访Kaplan-Meier估计显示门诊组一期通畅率(69% vs 53%,p=0.050)、辅助一期通畅率(90% vs 89%,p=0.646)及无截肢生存率(89% vs 83%,p=0.476)数值上更优,但差异未达统计学显著。
临床怎么用
- 作者认为,在适当选择患者的前提下,门诊腔内中心可作为医院血管造影室的安全替代方案。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
PURPOSE: To compare outcomes of outpatient tibial artery procedures between an office endovascular center and a hospital angiography suite. METHODS: A retrospective review was conducted of 204 outpatient tibial interventions performed on 161 patients (mean age 72±11.5 years; 81 men) in either an office (n=100) or hospital (n=104) angiography suite from April 2011 through September 2013. Patients who had an existing ipsilateral bypass that was completely proximal to the tibial trifurcation were eligible, as were patients with prior proximal endovascular interventions. Exclusion criteria included previous ipsilateral bypass involving the infrapopliteal vessels, in-patient status at the time of the procedure, planned admission after the procedure, and infrapopliteal stenting. Treatment included percutaneous transluminal angioplasty (PTA) or PTA with atherectomy. Primary outcomes were unplanned admission, emergency room visits, acute complications, and patency. RESULTS: There were no significant differences in demographics or baseline Rutherford category between patients treated in an office endovascular suite vs a hospital angiography suite. Factors more prevalent in the hospital group included chronic obstructive pulmonary disease (16% vs 8%, p=0.045), renal insufficiency (37% vs 25%, p=0.017), and previous proximal bypass (12% vs 4%, p=0.045). Of the 100 office procedures, 25 involved PTA and 75 were PTA with atherectomy, while in the 104 hospital procedures, PTA was applied in 68 patients and PTA with atherectomy in 36. Thirty-day local complication rates (7% vs 11%, p=0.368), systemic complication rates (4% vs 8%, p=0.263), and mortality (1% vs 2%, p=0.596) in the office vs hospital setting were not statistically different. Unplanned postprocedure hospital admission rates for medical reasons were lower in the office group (2% vs 11%, p=0.01). Kaplan-Meier estimates of the 1-year follow-up data were better in the office group for primary patency (69% vs 53%, p=0.050), assisted primary patency (90% vs 89%, p=0.646), and amputation-free survival (89% vs 83%, p=0.476), but the differences were not statistically significant. CONCLUSION: Efficacy and safety of outpatient endovascular tibial artery interventions between office and hospital settings were similar, with lower unplanned admission rates and better patency. With appropriate patient selection, the office endovascular suite can be a safe alternative to the hospital angiography suite.
引用
- D'Souza SM, Stout CL, Krol E, et al. Outpatient Endovascular Tibial Artery Intervention in an Office-Based Setting Is as Safe and Effective as in a Hospital Setting. J Endovasc Ther. 2018. PMID: 30318970. doi:10.1177/1526602818806691
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。